| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Davy Vancampfort, Joseph Firth, Christoph U Correll, Marco Solmi, Dan Siskind, Marc De Hert, Rebekah Carney, Ai Koyanagi, André F Carvalho, Fiona Gaughran, Brendon Stubb. The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials. World psychiatry : official journal of the World Psychiatric Association (WPA). vol 18. issue 1. 2021-01-09. PMID:30600626. |
switching from olanzapine to quetiapine or aripiprazole (smd=-0.71) and metformin (smd=-0.65) demonstrated best efficacy for reducing glucose levels, followed by glucagon-like peptide-1 receptor agonists (smd=-0.39), dietary interventions (smd=-0.37) and aripiprazole augmentation (smd=-0.34), whereas insulin resistance improved the most with metformin (smd=-0.75) and rosiglitazone (smd=-0.44). |
2021-01-09 |
2023-08-13 |
human |
| Eman M Khedr, Yasser Elserogy, Mohamed Fawzy, Ahmed A Abdelrahman, Amr M Galal, Mostafa M Noama. Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study. Psychiatry research. vol 291. 2020-12-31. PMID:32763548. |
the aim of this study was to assess the impact of the selective serotonin reuptake inhibitor, sertraline, and the atypical antipsychotic drugs quetiapine and olanzapine, on cortical excitability in unmedicated patients with major depressive disorder (mdd). |
2020-12-31 |
2023-08-13 |
human |
| Anna Maria Szota, Izabela Radajewska, Przemysław Grudzka, Aleksander Araszkiewic. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report. BMC psychiatry. vol 20. issue 1. 2020-12-21. PMID:32306929. |
neuroleptic malignant syndrome (nms) may be induced by atypical antipsychotic drugs (aapds) such as aripiprazole, olanzapine, risperidone and quetiapine, either as a single treatment or in combination with other drugs. |
2020-12-21 |
2023-08-13 |
Not clear |
| Yang Liu, Jun Liang, Qingrong Xia, Xin Zhou, Xuefeng Xi. Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in China. Neuropsychiatric disease and treatment. vol 16. 2020-11-13. PMID:33177826. |
to explore the therapeutic effects of lithium combined with second-generation antipsychotics (sgas) of quetiapine, clozapine, olanzapine, and risperidone for the treatment of manic episodes in patients with bipolar disorder (bd) to guide the selection of medications. |
2020-11-13 |
2023-08-13 |
Not clear |
| Sermin Kesebir, Burak Toprak, Burak Baykaran, Aytül Hariri, Mustafa Bilic. Comparison of Sexual Function and Hormonal Parameters Between Mood Stabilizer Treatment Modalities in Bipolar Disorder. Noro psikiyatri arsivi. vol 51. issue 3. 2020-10-01. PMID:28360633. |
the aim of this study was to determine the differences between lithium and atypical antipsychotics (quetiapine and olanzapine) with regard to their effects on sexual functions and hormonal variables and to assess the findings in term of gender differences, in patients with bipolar disorder. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ayça Kiliç, Evrim Erten, Armağan Özdemi. Tardive Blepharospasm and Meige Syndrome during Treatment with Quetiapine and Olanzapine. Noro psikiyatri arsivi. vol 52. issue 2. 2020-10-01. PMID:28360708. |
tardive blepharospasm and meige syndrome during treatment with quetiapine and olanzapine. |
2020-10-01 |
2023-08-13 |
Not clear |
| Jong-Hyun Jeong, Won-Myong Bahk, Young Sup Woo, Jung Goo Lee, Moon-Doo Kim, InKi Sohn, Se-Hoon Shim, Duk-In Jon, Jeong Seok Seo, Won Kim, Hoo-Rim Song, Kyung Joon Min, Bo-Hyun Yoo. Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 17. issue 2. 2020-10-01. PMID:30905116. |
quetiapine, olanzapine and aripiprazole were the first-line aaps for nearly all phases of bipolar disorder across guidelines. |
2020-10-01 |
2023-08-13 |
Not clear |
| Konstantinos N Fountoulakis, Ioannis Nimatoudis, Apostolos Iacovides, George Kaprini. Off-label indications for atypical antipsychotics: A systematic review. Annals of general hospital psychiatry. vol 3. issue 1. 2020-09-30. PMID:14975068. |
material and method: medline was searched with the combination of each one of the key words: risperidone, olanzapine and quetiapine with key words that refered to every dsm-iv diagnosis other than schizophrenia and other psychotic disorders, bipolar disorder and dementia and memory disorders. |
2020-09-30 |
2023-08-12 |
Not clear |
| Adriano Aquino, Guilherme L Alexandrino, Paul C Guest, Fabio Augusto, Alexandre F Gomes, Michael Murgu, Johann Steiner, Daniel Martins-de-Souz. Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients. Frontiers in psychiatry. vol 9. 2020-09-30. PMID:29887809. |
blood-based lipidomics approach to evaluate biomarkers associated with response to olanzapine, risperidone, and quetiapine treatment in schizophrenia patients. |
2020-09-30 |
2023-08-13 |
Not clear |
| Daisy Ng-Mak, Andrew Messali, Ahong Huang, Li Wang, Antony Loebe. Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics. The American journal of managed care. vol 25. issue 14 Suppl. 2020-09-23. PMID:31365818. |
this study compared the risk of hospitalization among adults with schizophrenia being treated with equivalent dose ranges of lurasidone versus aripiprazole, olanzapine, quetiapine, or risperidone. |
2020-09-23 |
2023-08-13 |
Not clear |
| Tanja Veselinović, Martin Scharpenberg, Martin Heinze, Joachim Cordes, Bernd Mühlbauer, Georg Juckel, Ute Habel, Eckart Rüther, Jürgen Timm, Gerhard Gründe. Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 29. issue 6. 2020-08-07. PMID:30981585. |
the aim of our multi-center, randomized, double-blind "neuroleptic strategy study" (nessy) was to compare the effectiveness of selected antipsychotics, conventionally classified as second- (sgas) (haloperidol, flupentixol) and first generation antipsychotics (fgas) (aripiprazole, olanzapine, quetiapine), on quality of life in schizophrenia. |
2020-08-07 |
2023-08-13 |
Not clear |
| Louise Wingård, Lena Brandt, Robert Bodén, Helle Kieler, Morten Andersen, Johan Reutfor. Monotherapy vs. combination therapy for post mania maintenance treatment: A population based cohort study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 29. issue 6. 2020-08-07. PMID:31078359. |
all patients aged 18-75 years who were hospitalized for mania 2006-2014 and filled at least one prescription of lithium, valproate, olanzapine, quetiapine, aripiprazole or any combination of these drugs were included, and followed for up to one year after hospital discharge, generating follow-up data from 5 713 hospitalizations. |
2020-08-07 |
2023-08-13 |
Not clear |
| Taro Kishi, Toshikazu Ikuta, Yuki Matsuda, Nakao Iwat. Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis. Neuropsychopharmacology reports. vol 39. issue 3. 2020-06-29. PMID:31283865. |
quetiapine extended-release vs olanzapine for japanese patients with bipolar depression: a bayesian analysis. |
2020-06-29 |
2023-08-13 |
Not clear |
| Taro Kishi, Toshikazu Ikuta, Yuki Matsuda, Nakao Iwat. Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis. Neuropsychopharmacology reports. vol 39. issue 3. 2020-06-29. PMID:31283865. |
it is unknown whether there are differences in efficacy and safety between quetiapine extended-release, 300 mg/d (quexr300), and olanzapine, 5-20 mg/d (ola), for japanese patients with bipolar depression. |
2020-06-29 |
2023-08-13 |
Not clear |
| Marie Tournier, Anke Neumann, Elodie Pambrun, Alain Weill, Jean-Philippe Chaffiol, François Alla, Bernard Bégaud, Géric Maura, Hélène Verdou. Conventional mood stabilizers and/or second-generation antipsychotic drugs in bipolar disorders: A population-based comparison of risk of treatment failure. Journal of affective disorders. vol 257. 2020-06-29. PMID:31306992. |
the study compared treatment failure when using three therapeutic strategies in bipolar disorders: (i) mood stabilizers (mss: lithium, valpromide, divalproate, carbamazepine, lamotrigine) without second-generation antipsychotic (sgap); (ii) sgaps (aripiprazole, olanzapine, risperidone, quetiapine) without ms; (iii) combination of mss and sgaps. |
2020-06-29 |
2023-08-13 |
Not clear |
| Davide Martino, Vikram Karnik, Sydney Osland, Thomas R E Barnes, Tamara M Pringshei. Movement Disorders Associated With Antipsychotic Medication in People With Schizophrenia: An Overview of Cochrane Reviews and Meta-Analysis. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2020-02-25. PMID:29758999. |
we conducted meta-analyses of randomised controlled trials included in the cochrane database of systematic reviews on schizophrenia and schizophrenia-like psychoses to estimate the prevalence of new-onset dystonia, akathisia, parkinsonism, and tremor with sgas (amisulpride, asenapine, aripiprazole, clozapine, olanzapine, paliperidone, quetiapine, risperidone, l-sulpiride, and ziprasidone) approved in canada and the uk, comparing them with haloperidol and chlorpromazine. |
2020-02-25 |
2023-08-13 |
Not clear |
| Alexander Kiss, Jana Osack. Spatial relationship between the c-Fos distribution and enkephalinergic, substance P, and tyrosine hydroxylase innervation fields after acute treatment with neuroleptics olanzapine, amisulpride, quetiapine, and aripiprazole in the rat septum. Endocrine regulations. vol 53. issue 3. 2020-02-12. PMID:31517634. |
spatial relationship between the c-fos distribution and enkephalinergic, substance p, and tyrosine hydroxylase innervation fields after acute treatment with neuroleptics olanzapine, amisulpride, quetiapine, and aripiprazole in the rat septum. |
2020-02-12 |
2023-08-13 |
rat |
| Alexander Kiss, Jana Osack. Spatial relationship between the c-Fos distribution and enkephalinergic, substance P, and tyrosine hydroxylase innervation fields after acute treatment with neuroleptics olanzapine, amisulpride, quetiapine, and aripiprazole in the rat septum. Endocrine regulations. vol 53. issue 3. 2020-02-12. PMID:31517634. |
the aim of the present study was to demonstrate the spatial relationship between the c-fos immunoreactive cells elicited by an acute treatment with neuroleptics including amisulpride (ami), olanzapine (ola), quetiapine (que), and aripiprazole (ari) and enkephalinergic (enk), substance p (sp), and tyrosine hydroxylase (th) innervation fields in the rat septum. |
2020-02-12 |
2023-08-13 |
rat |
| Alexander Kiss, Romana Koprdova, Jana Osacka, Jan Pecena. c-Fos expression response to olanzapine, amisulpride, aripiprazole, and quetiapine single administration in the rat forebrain: Effect of a mild stress preconditioning. Neurochemistry international. vol 126. 2019-12-10. PMID:30905743. |
c-fos expression response to olanzapine, amisulpride, aripiprazole, and quetiapine single administration in the rat forebrain: effect of a mild stress preconditioning. |
2019-12-10 |
2023-08-13 |
rat |
| Summon Chomchai, Jariya Phuditshinnapatra, Pattaraporn Mekavuthikul, Chulathida Chomcha. Effects of unconventional recreational drug use in pregnancy. Seminars in fetal & neonatal medicine. vol 24. issue 2. 2019-11-26. PMID:30744980. |
in this articles, obstetric complications, teratogenicity and neonatal abstinence syndrome from exposure during pregnancy to synthetic cannabinoids, synthetic cathinones, tramadol, kratom, olanzapine, quetiapine, ketamine and ketamine are reviewed. |
2019-11-26 |
2023-08-13 |
Not clear |